SCHEMBL26313170

SCHEMBL26313170

COc1ccc(Cn2cc(-c3cc(C(F)F)nc(Sc4cccc(NC(C)=O)c4)n3)ccc2=O)cc1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MKNK1 Q9BUB5 2/20 0.46
▸ MKNK2 Q9HBH9 2/20 0.46
▸ SDHB P21912 10/20 0.46
▸ MAPT P10636 4/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ STAT3 P40763 1/20 0.40
▸ LMNA P02545 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ FYN P06241 1/20 0.37
▸ USP2 O75604 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ BRAF P15056 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26313167 0.92 SDHB (0.44) MKNK1MKNK2SDHBMAPTMEN1
SCHEMBL26313146 0.88 SDHB (0.49) SDHBMAPTMEN1KMT2ATP53
SCHEMBL26313164 0.88 SDHB (0.49) MKNK1MKNK2SDHBMAPTTP53
SCHEMBL20985710 0.84 SDHB (0.54) MKNK1MKNK2SDHBMAPTMEN1
SCHEMBL19805843 0.82 SDHB (0.55) SDHBMAPTSMN1; SMN2LMNATP53
SCHEMBL19805988 0.80 SDHB (0.53) SDHBMAPTALDH1A1MAPK1SMN1; SMN2
SCHEMBL19806088 0.78 SDHB (0.54) SDHBMAPTTP53
SCHEMBL26313143 0.77 SDHB (0.57) SDHBMAPTSMN1; SMN2LMNATP53
SCHEMBL22912277 0.77 SDHB (0.48) SDHBMAPTTP53RXFP1
SCHEMBL26313158 0.76 SDHB (0.52) MKNK1MKNK2SDHB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11725000-B2 Apoptosis inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2023-08-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11725000-B2 Apoptosis inhibitors BAX, SDHA, SDHB MKNK1 1954/4885MKNK2 2039/4885SDHB 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback